The agency is celebrating the achievement of key first year goals in implementing the Roadmap to Reducing Animal Testing in ...

From PCR to next-gen sequencing, molecular diagnostics are revolutionizing how we detect infectious diseases—offering faster, more sensitive, and more precise results than traditional cultures. These ...

Each year on April 24, scientists, advocates, and policymakers around the world mark World Day for Laboratory Animals—a ...

US FDA achieves year 1 goals in reducing animal testing in drug development: Silver Spring, Maryland Wednesday, April 22, 2026, 16:00 Hrs [IST] The US Food and Drug Administration ...

LC-MS/MS remains central for PFAS quantification because ESI efficiently ionizes strongly acidic, predominantly anionic PFAAs ...

CancerCheck is a one-of-a-kind early-detection blood test that, for the first time, can extract whole circulating tumor cells (CTCs), enabling a board-certified pathologist to ...

Researchers at Kent have established a computational protocol that could accelerate the development of more effective ...

As drug development becomes more complex, so do the demands for accurate, reproducible bioanalytical data to prove their safety and efficacy. Method validation ensures the reliability of ...

Colorectal cancer (CRC) is the second most common cause of cancer death in the United States and disproportionally impacts people who receive care in under-resourced settings.

Utepreva LLC today announced the launch of the Utepreva Endometrial Sampler, a patented, FDA 510(k)-cleared, single-use endometrial sampling device engineered to enhance tissue capture and support ...

Will Kenton is an expert on the economy and investing laws and regulations. He previously held senior editorial roles at Investopedia and Kapitall Wire and holds a MA in Economics from The New School ...

Liver scarring can pave the way to cancer down the line. A new blood test in development might help doctors spot it.